Results 21 to 30 of about 56,795 (260)

Nonsystemic vasculitic neuropathy

open access: yesMedical Journal of Dr. D.Y. Patil Vidyapeeth, 2020
A 21-year-old female born of nonconsanguineous marriage presented with gradually progressive quadriplegia for 3 years. Weakness was distal more than proximal, with wasting. She also had moderate pain in extremities.
Shalesh Rohatgi   +2 more
doaj   +1 more source

Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus [PDF]

open access: yes, 2015
Introduction ES-62, a phosphorylcholine (PC)-containing immunomodulator secreted by the parasitic worm Acanthocheilonema viteae, protects against nephritis in the MRL/Lpr mouse model of systemic lupus erythematosus (SLE).
Harnett, M. M.   +4 more
core   +1 more source

Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis. [PDF]

open access: yes, 2009
Background: Recent evidence suggests that distinction of subsets of rheumatoid arthritis (RA) depending on anticyclic citrullinated peptide antibody (anti-CCP) status may be helpful in distinguishing distinct aetiopathologies and in predicting the ...
Burmester, G.R.   +7 more
core   +1 more source

CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren’s syndrome patients and correlates with focus score and disease activity [PDF]

open access: yes, 2017
Background: Primary Sjögren’s syndrome (pSS) is a common chronic autoimmune disease characterized by lymphocytic infiltration of exocrine glands and peripheral lymphocyte perturbation.
A Bhattacharya   +58 more
core   +3 more sources

Lupus-like nephritis with positive anti-neutrophil cytoplasmic antibodies and negative antinuclear antibodies

open access: yesBrazilian Journal of Nephrology, 2020
Antineutrophil cytoplasmic antibodies (ANCAs) are associated with small vessel vasculitis but their prevalence is not rare in other immune diseases.
Joana Eugénio Santos   +6 more
doaj   +2 more sources

Antinuclear Antibodies: A demographic profile from a Tertiary Healthcare Centre of Delhi

open access: yesSVU - International Journal of Medical Sciences, 2023
Background: Anti-nuclear autoantibodies (ANA), have explicitly been linked to immune complex-mediated autoimmune diseases. Detection and quantitation of autoantibodies are therefore crucial in the diagnosis and treatment.
Krishna Sarkar   +3 more
doaj   +1 more source

Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database. [PDF]

open access: yes, 2017
Racial differences exist in the severity of systemic sclerosis (SSc). To enhance our knowledge about SSc in African Americans, we established a comprehensive clinical database from the largest multicenter cohort of African American SSc patients assembled
Boin, Francesco   +28 more
core   +1 more source

Intracellular and circulating neuronal antinuclear antibodies in human epilepsy

open access: yesNeurobiology of Disease, 2013
There are overwhelming data supporting the inflammatory origin of some epilepsies (e.g., Rasmussen's encephalitis and limbic encephalitis). Inflammatory epilepsies with an autoimmune component are characterized by autoantibodies against membrane-bound ...
Philip H. Iffland, II   +8 more
doaj   +1 more source

Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics. [PDF]

open access: yesPLoS ONE, 2015
With the emergence of biotherapies, accurate diagnosis in early arthritis is needed. At this time, there is no biological marker of psoriatic arthritis.To test whether antinuclear antibodies (ANA) can be used as a diagnostic tool in psoriatic arthritis ...
Florent Silvy   +8 more
doaj   +1 more source

Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?

open access: yesTurkish Journal of Hematology, 2022
Objective: Eltrombopag remains a prominent option in the treatment of steroid-dependent or steroid-refractory immune thrombocytopenia (ITP) patients. Unfortunately, not all patients respond to eltrombopag.
Mehmet Baysal   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy